Compare Bit Digital Inc (BTBT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

BTBT trades at $1.44, up 10.77% over 24 hours, but faces a bearish technical outlook with 14 sell signals against 2 buy signals. The company reported a net loss of $80.32 million in 2025, with a negative net income margin of -145.45%, though it maintains a gross profit margin of 55.57%. Recent earnings have been mixed, with a beat in Q3 2025 but misses in subsequent quarters. The stock is closely watched by investors ahead of its Q2 2026 earnings release on August 13, 2026.

The outlook is challenged by persistent losses and negative cash flow from operations, offset by strong financing inflows. Analyst consensus is bullish with a 100% buy rating from two firms and a $5.12 average price target, suggesting significant upside potential if the company can improve profitability. Key risks include execution challenges, competitive pressures, and reliance on external financing to sustain operations.

ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.

The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.